In this talk, Associate Professor Suresh Muthukumaraswamy describes the recent renaissance of psychedelic drug research and the pathway for psychedelics to be introduced as important new medicines.

This talk was part of the 2021 home edition of the Raising the Bar series, where academics talk about research breakthroughs, issues and how the world is changing.

Suresh Muthukumaraswamy is an Associate Professor in Pharmacy at the University of Auckland. His main research interests are in understanding how therapies alter brain activity and in developing methodologies to measure these changes in both healthy individuals and patient groups.

For more of our audio and visual content, check out our YouTube channel, or head to the University of Auckland’s manuscripts and archives collection.

Disclaimer: The ideas expressed in this talk reflect the views of the guest and not necessarily the views of The Big Q. 

You might also like:

What is a hallucinogen? What these mind-altering drugs do in our brains 

Can MDMA help people with autism overcome social anxiety?